Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
US FDA Observation
High Gain High Volume
|
Mid-range Performer
927.4000
93.40
(
11.20
%)
NSE
Nov 26, 2025
15:31 PM
38.38% Fall from 52W High
Volume:
19.5M
High volume+gain today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
17 Nov 2022
US FDA Observation
High Gain High Volume
927.40
11.20%
Natco Pharma
Hold:
Natco Pharma Ltd.
by
ICICI Direct
Target: 660
Target
ICICI Direct
Natco Pharma Ltd. has lost
-32.06%
in the last 1 Year
More from Natco Pharma Ltd.
Recommended
Market closes higher, buoyed by lower oil prices and anticipation of Fed rate cut
Trendlyne Marketwatch |
26 Nov 2025, 04:04PM
Five stocks to buy from analysts this week - November 26, 2025
The Baseline |
26 Nov 2025, 11:57AM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020